Related Experiment Video
Updated: Aug 18, 2026
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Insights
Early thrombolytic therapy for acute myocardial infarction (MI) dissolves coronary artery blockages, interrupting ischemia and improving patient outcomes. Prompt emergency department intervention maximizes benefits, including reduced mortality and preserved left ventricular function (LVF).
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Acute myocardial infarction (MI) pathophysiology involves obstructive coronary thrombi causing ischemia.
- Thrombolytic therapy offers a method to dissolve these obstructive thrombi.
- Clinical trials have investigated tissue plasminogen activator (t-PA) and streptokinase (SK).
Purpose of the Study:
- To evaluate the benefits of thrombolytic therapy in acute MI.
- To emphasize the importance of early intervention in the emergency setting.
- To highlight the role of emergency physicians and nurses in MI treatment.
Main Methods:
- Administration of thrombolytic agents (t-PA, SK) to dissolve coronary thrombi.
- Clinical trials assessing patient outcomes.
- Evaluation of treatment timing and setting (emergency department).
Main Results:
- Thrombolytic therapy demonstrated preservation of left ventricular function (LVF).
- Significant reductions in congestive heart failure incidence were observed.
- Clinical trials showed a reduction in mortality rates.
Conclusions:
- Early intervention with thrombolytic therapy is crucial for maximal patient benefit in acute MI.
- Treatment in the emergency setting is safe and feasible.
- Prompt emergency department administration of thrombolytics offers the greatest opportunity for positive patient outcomes.
Abstract:
It is now possible through the administration of thrombolytic therapy to dissolve an obstructive thrombus in the coronary artery. On the basis of the pathophysiology of acute MI, this should translate into interruption of the ischemic process and benefit to the patient. Clinical trials with t-PA and SK have supported this concept by demonstrating preservation of LVF, reduction in congestive heart failure, and reduction in mortality. All clinical data point to the importance of early intervention and treatment in attaining maximal patient benefit. Studies have shown the safety and feasibility of early treatment in the emergency setting. In the era of thrombolytic therapy, there is an opportunity for the emergency physician and nurse to play a significant role in the treatment of the patient with acute MI. Prompt intervention with thrombolytic therapy in the emergency department will offer the patient the greatest opportunity for benefit.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:29Venous Thrombosis III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care